GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Beneish M-Score

Integra Lifesciences Holdings (FRA:IL3) Beneish M-Score : -2.57 (As of May. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.57 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Integra Lifesciences Holdings's Beneish M-Score or its related term are showing as below:

FRA:IL3' s Beneish M-Score Range Over the Past 10 Years
Min: -2.79   Med: -2.56   Max: -2.14
Current: -2.57

During the past 13 years, the highest Beneish M-Score of Integra Lifesciences Holdings was -2.14. The lowest was -2.79. And the median was -2.56.


Integra Lifesciences Holdings Beneish M-Score Historical Data

The historical data trend for Integra Lifesciences Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Beneish M-Score Chart

Integra Lifesciences Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.63 -2.79 -2.65 -2.45 -2.57

Integra Lifesciences Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.45 -2.48 -2.45 -2.50 -2.57

Competitive Comparison of Integra Lifesciences Holdings's Beneish M-Score

For the Medical Devices subindustry, Integra Lifesciences Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integra Lifesciences Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Integra Lifesciences Holdings's Beneish M-Score falls into.



Integra Lifesciences Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Integra Lifesciences Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9916+0.528 * 1.085+0.404 * 1.0099+0.892 * 0.9642+0.115 * 1.0247
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0784+4.679 * -0.020179-0.327 * 1.0696
=-2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €238 Mil.
Revenue was 364.085 + 358.328 + 351.909 + 355.71 = €1,430 Mil.
Gross Profit was 207.694 + 204.589 + 191.085 + 217.502 = €821 Mil.
Total Current Assets was €970 Mil.
Total Assets was €3,468 Mil.
Property, Plant and Equipment(Net PPE) was €455 Mil.
Depreciation, Depletion and Amortization(DDA) was €115 Mil.
Selling, General, & Admin. Expense(SGA) was €609 Mil.
Total Current Liabilities was €282 Mil.
Long-Term Debt & Capital Lease Obligation was €1,515 Mil.
Net Income was 18.188 + 18.269 + 3.862 + 22.627 = €63 Mil.
Non Operating Income was 1.846 + 0.441 + -0.143 + 1.297 = €3 Mil.
Cash Flow from Operations was 53.874 + 25.083 + 26.102 + 24.43 = €129 Mil.
Total Receivables was €249 Mil.
Revenue was 375.733 + 389.043 + 376.333 + 341.987 = €1,483 Mil.
Gross Profit was 236.08 + 239.113 + 235.943 + 212.535 = €924 Mil.
Total Current Assets was €1,096 Mil.
Total Assets was €3,672 Mil.
Property, Plant and Equipment(Net PPE) was €434 Mil.
Depreciation, Depletion and Amortization(DDA) was €113 Mil.
Selling, General, & Admin. Expense(SGA) was €586 Mil.
Total Current Liabilities was €303 Mil.
Long-Term Debt & Capital Lease Obligation was €1,475 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(237.803 / 1430.032) / (248.711 / 1483.096)
=0.166292 / 0.167697
=0.9916

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(923.671 / 1483.096) / (820.87 / 1430.032)
=0.622799 / 0.574022
=1.085

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (970.219 + 455.183) / 3468.083) / (1 - (1096.454 + 433.849) / 3671.932)
=0.588994 / 0.583243
=1.0099

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1430.032 / 1483.096
=0.9642

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(112.608 / (112.608 + 433.849)) / (114.586 / (114.586 + 455.183))
=0.206069 / 0.20111
=1.0247

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(609.201 / 1430.032) / (585.859 / 1483.096)
=0.426005 / 0.395024
=1.0784

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1514.762 + 281.501) / 3468.083) / ((1475.104 + 302.935) / 3671.932)
=0.517941 / 0.484224
=1.0696

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(62.946 - 3.441 - 129.489) / 3468.083
=-0.020179

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Integra Lifesciences Holdings has a M-score of -2.60 suggests that the company is unlikely to be a manipulator.


Integra Lifesciences Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Integra Lifesciences Holdings (FRA:IL3) Business Description

Traded in Other Exchanges
Address
1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings (FRA:IL3) Headlines

No Headlines